News Feed

Most people associate the gut microbiome with bacteria, but fungi and archaea also play vital roles in digestion, immunity, and metabolism. Beneficial fungi such as Saccharomyces boulardii may protect the gut from inflammation, while an overgrowth of Candida has been linked to digestive and metabolic disorders. Meanwhile, archaea like Methanobrevibacter smithii help bacteria break down food more efficiently but may also contribute to constipation and altered energy extraction. Researchers believe that the balance between bacteria, fungi, and archaea is essential for overall health. Although these findings are promising, most remain research-based, and more studies are needed before microbiome-targeted therapies become routine clinical practice.

Monsoon is the perfect season to enjoy fresh, nutrient-rich fruits that support immunity and digestive health. According to dietitians, fruits like jamun, pomegranate, papaya, pears, plums, peaches, and apples are packed with antioxidants, vitamins, and fiber that help protect against seasonal infections and promote gut health. Papaya contains the digestive enzyme papain, while jamun may support healthy blood sugar levels when eaten in moderation. To stay safe, always choose fresh whole fruits, wash them thoroughly under running water, and avoid pre-cut fruits sold by roadside vendors. Pairing fruits with a handful of nuts or seeds can also improve satiety and help maintain steadier blood sugar levels.

Scientists have uncovered a surprising way certain lung cancers may trigger cachexia—a serious condition causing severe weight and muscle loss. In mouse studies, researchers found that some lung tumors communicate directly with the brain through sensory nerves in the lungs using a signaling molecule called prostaglandin E2 (PGE2). Disrupting this nerve communication or reducing PGE2 production, including through omega-3-rich diets, significantly reduced cachexia. Common anti-inflammatory drugs like aspirin and ibuprofen also showed similar effects in early experiments. Although these findings are still preclinical and require human studies, they could pave the way for new treatments that improve quality of life and outcomes for patients with lung cancer.

A new study suggests that a routine blood test could help identify heart attack patients at the highest risk of dying within the first 30 days. Researchers found that severe heart attacks trigger the release of immature neutrophils, a type of white blood cell, from the bone marrow into the bloodstream. Higher levels of these immature granulocytes (IGs) were strongly linked to poorer survival and outperformed several established risk markers. Because IG levels can be measured using a standard blood count available in most hospitals, this approach could help doctors quickly identify high-risk patients for closer monitoring. However, larger studies are still needed before the test becomes part of routine clinical care.

A new mouse study suggests that ovaries remain biologically active even after they stop producing eggs. Instead of becoming inactive, post-reproductive ovaries appear to shift from supporting reproduction to regulating immune and inflammatory processes. Researchers found that aging ovaries lost their reproductive functions but became enriched with immune cells, including T cells and macrophages, while activating genes linked to inflammation and white blood cell activity. The ovaries also released signaling molecules that could influence the rest of the body. Although these findings still need confirmation in humans, they challenge the long-held belief that ovaries become inactive after menopause and may open new avenues for treating age-related inflammatory diseases in postmenopausal women.

A new scientific review proposes that sleep does far more than restore energy—it helps keep the brain's complex neural networks stable and adaptable. According to researchers, deep NREM sleep strengthens resilience by resetting overactive neural connections, while REM sleep promotes flexibility by reorganizing brain circuits. Together, these stages prevent the brain from becoming overloaded or locked into unhealthy patterns. Deep sleep also activates the brain's waste-clearing glymphatic system, helping remove harmful proteins linked to neurodegenerative diseases. Although this is a theory-based review rather than a new experiment, the findings may improve our understanding of conditions such as Alzheimer's disease, epilepsy, and schizophrenia, while also inspiring smarter artificial intelligence systems.

Scientists have discovered that a group of cells long linked to aging may actually play a vital role in repairing injured tendons. In mouse studies, p16INK4a+ cells rapidly accumulated after tendon injury and promoted collagen production, blood vessel growth, and tissue regeneration. When these cells were removed, healing was weaker, with disorganized collagen and increased inflammation. Researchers also identified JMJD3, an epigenetic regulator, as a key switch that activates repair genes in these cells. Blocking JMJD3 impaired healing, while enhancing its activity improved tendon strength and collagen organization. These findings challenge the belief that all aging-related cells are harmful and could lead to new treatments that promote faster, stronger tendon repair.

Scientists have developed a promising experimental drug that may help slow the progression of amyotrophic lateral sclerosis (ALS) by protecting nerve cells from damage. In a new study, researchers identified a small harmful region within the TDP-43 protein, which forms toxic clumps in nearly all ALS cases. The experimental drug, XL20, targets this region without disrupting the protein's normal function. In mouse models, XL20 improved survival, reduced muscle weakness, and protected nerve cells. It also reversed key signs of damage in human motor neurons grown in the lab. While more research and clinical trials are needed, this discovery could pave the way for new treatments for ALS and other TDP-43-related neurodegenerative diseases.

Researchers have developed an innovative synthetic bone graft that could transform the treatment of bone cancer. By adding gallium oxide to a bioactive glass material, the new graft not only helps regenerate lost bone but also destroys remaining cancer cells and prevents bacterial infections after surgery. Cancer cells absorb much more gallium than healthy cells, triggering processes that lead to their self-destruction while leaving normal bone cells largely unharmed. The material also completely blocked the growth of the dangerous bacterium Pseudomonas aeruginosa in laboratory tests. Although further clinical studies are needed, this multifunctional graft could improve limb-sparing surgery outcomes and reduce the risk of cancer recurrence and infection.

A new study suggests that a circulating tumor DNA (ctDNA) blood test could help identify colorectal cancer patients who are most likely to benefit from chemotherapy after surgery. Researchers found that patients whose cancer had spread to the liver and who tested positive for ctDNA after surgery experienced significantly better survival when they received adjuvant chemotherapy compared with those who did not. In contrast, patients with no detectable ctDNA had good long-term outcomes regardless of chemotherapy, raising the possibility of avoiding unnecessary treatment and its side effects. While these findings are promising, experts stress that larger randomized clinical trials are still needed before ctDNA-guided treatment becomes routine clinical practice.